Stewart, D A <br/><br/>
The CD34+90+ cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34+ cell dose.  [electronic resource] 

 -  Bone marrow transplantation  Feb 2000 
 - 435-40 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1702171  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, CD34<br/>Biomarkers<br/>Blood Cell Count<br/>Female<br/>Graft Survival--immunology<br/>Hematopoietic Stem Cell Transplantation<br/>Hematopoietic Stem Cells--immunology<br/>Humans<br/>Immunophenotyping<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Thy-1 Antigens<br/>Transplantation, Autologous